Perseus Proteomics Inc. [4882.T]
TOKYO, May 20 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) announced plans to amend its articles of incorporation at its upcoming annual shareholders' meeting scheduled for May 20, 2026.
The proposed changes aim to expand and diversify its business operations, enhance capital flexibility, and improve governance structures. Key amendments include adding new business purposes related to medical products, animal pharmaceuticals, and life science-related industrial goods; increasing the total number of authorized shares to 50,000,000; clarifying the term lengths for newly appointed directors; and allowing virtual-only shareholder meetings. Additionally, the proposal would grant the board authority to decide on surplus distribution matters without requiring shareholder approval.
Furthermore, the company confirmed receipt of necessary approvals from the Ministry of Economy, Trade and Industry and the Ministry of Justice regarding the proposed changes. The revised articles will take effect upon shareholder approval at the meeting on May 20, 2026. In preparation for future operational needs, Perseus Proteomics seeks to ensure robust internal controls and effective oversight through enhanced collaboration between audit committees and internal audit departments.
The company also emphasizes its commitment to maintaining high standards of corporate governance while adapting to evolving regulatory requirements.
🟡 Confidence: Standard AI-translated content.